2024-11-04T11:32:55-06:00 2023-12-31 951777440 GREEN HASSON & JANKS LLP 700 S FLOWER STREET SUITE 3300 LOS ANGELES CA 90017 990 2023-01-01 261636099 MELANOMA RESEARCH ALLIANCE FOUNDATION MELA 2023367230 730 15TH ST NW 4TH FLOOR WASHINGTON DC 20005 MARC HURLBERT CEO 2023367230 2024-11-01 1 1 LIZBETH G NEVAREZ P01399868 3108731600 2024-11-01 2023 2024-10-15 13:58:12Z MARC HURLBERT 730 15TH ST NW 4TH FLOOR WASHINGTON DC 20005 9575580 0 X WWW.CUREMELANOMA.ORG X 2007 DE TO ACCELERATE SCIENTIFIC DISCOVERY TO ELIMINATE SUFFERING AND DEATH DUE TO MELANOMA 25 24 12 44 0 0 11591019 8539530 0 0 320977 905624 -297357 -153456 11614639 9291698 11957652 6600342 0 0 2049760 1945290 0 0 812626 1660901 1770885 15668313 10316517 -4053674 -1024819 27333346 24538655 13480531 11530586 13852815 13008069 X TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS. 0 0 8424245 6600342 0 THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, SELECTED THROUGH A PEER-REVIEW PANEL AND INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO PREVENT, DETECT AND TREAT MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO MORE EFFECTIVE PREVENTION, EARLIER DETECTION AND BETTER TREATMENTS FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC AND FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY. 471516 0 0 THE MRA OPERATES A PATIENT ENGAGEMENT PROGRAM THAT SUPPORTS INCREASED AWARENESS OF MELANOMA IN GENERAL, AND OF PREVENTION, DETECTION AND TREATMENT OPTIONS SPECIFICALLY. THE PATIENT ENGAGEMENT PROGRAM ALSO PROVIDES EDUCATION ABOUT AND PROMOTION OF CLINICAL TRIALS. THE PATIENT ENGAGEMENT PROGRAM INCLUDES DEVELOPMENT AND DISTRIBUTION OF EDUCATIONAL MATERIALS, THE PROVISION OF EDUCATIONAL FORUMS, A CLINICAL TRIAL NAVIGATOR FOR PATIENTS AND AN ON-LINE PATIENT COMMUNITY. 8895761 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 14 0 1 12 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 25 24 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI MS X X MARC HURLBERT PHD 2023367230 730 15TH ST NW 4TH FLOOR WASHINGTON DC 20005 MICHAEL KLOWDEN DIRECTOR 0.30 40.00 X 0 421390 56759 JOHN HUNTER TREASURER 1.00 40.00 X 0 490307 73124 MARC HURLBERT CHIEF EXECUTIVE OFFICER 50.00 0.00 X 378659 0 35440 STEPHANIE KAUFFMAN PRESIDENT & COO 50.00 0.00 X 300852 0 66328 JOAN LEVY CHIEF SCIENCE OFFICER 40.00 0.00 X 198854 0 28311 TANISHA JACKSON SCIENTIFIC PROGRAM DIRECTOR 40.00 0.00 X 155659 0 26246 CODY BARNETT SENIOR DIRECTOR COMMUNICATIONS 40.00 0.00 X 134825 0 12963 JANINE RAUSCHER DIR. OF DEVELOPMENT OPERATIONS 40.00 0.00 X 103698 0 5491 DEBRA BLACK CHAIR/CO-FOUNDER 10.00 0.00 X X 0 0 0 EVAN BAYH DIRECTOR/SECRETARY 0.50 0.00 X X 0 0 0 LEON BLACK DIRECTOR/CO-FOUNDER 0.30 0.00 X 0 0 0 LEE ALPERT DIRECTOR 0.30 0.00 X 0 0 0 MARIA BELL DIRECTOR 0.30 0.00 X 0 0 0 BEN BLACK DIRECTOR 0.30 0.00 X 0 0 0 BARRY COHEN DIRECTOR 0.30 0.00 X 0 0 0 ELLEN DAVIS DIRECTOR 0.30 0.00 X 0 0 0 AMANDA EILIAN DIRECTOR 0.30 0.00 X 0 0 0 JASON FEDERICI DIRECTOR 0.30 0.00 X 0 0 0 JAMI GERTZ DIRECTOR 0.30 0.00 X 0 0 0 DAISY HELMAN DIRECTOR 0.30 0.00 X 0 0 0 SUSAN HESS DIRECTOR 0.30 0.00 X 0 0 0 DENISE KELLEN DIRECTOR 0.30 0.00 X 0 0 0 NANCY MARKS DIRECTOR 0.30 0.00 X 0 0 0 MICHAEL MILKEN DIRECTOR 0.30 0.00 X 0 0 0 RICHARD RESSLER DIRECTOR 0.30 0.00 X 0 0 0 MARY JO ROGERS DIRECTOR 0.30 0.00 X 0 0 0 JEFFREY ROWBOTTOM DIRECTOR 0.30 0.00 X 0 0 0 IAN SCHUMAN DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SIMONS DIRECTOR 0.30 0.00 X 0 0 0 JONATHAN SOKOLOFF DIRECTOR 0.30 0.00 X 0 0 0 ELIZABETH STANTON DIRECTOR 0.30 0.00 X 0 0 0 SUZANNE TOPALIAN DIRECTOR 1.00 0.00 X 0 0 0 1272547 911697 304662 6 0 1 0 KWT GLOBAL LLC ONE WORLD TRADE CENTER FLOOR 69 NEW YORK NY 10007 PR & COMMUNICATIONS 119215 1 3023020 5516510 153244 8539530 905624 905624 122600 3023020 283882 -161282 -161282 OTHER INCOME 900099 7826 7826 7826 9291698 0 0 752168 6175342 6175342 425000 425000 1008534 577704 193623 237207 731599 419071 140456 172072 30964 17736 5945 7283 75333 43152 14463 17718 98860 56628 18980 23252 105391 105391 23306 23306 300107 180112 44035 75960 12875 4126 739 8010 42296 13880 2427 25989 203710 71571 28767 103372 101270 89995 5689 5586 503582 477278 18151 8153 415778 324117 2565 89096 DUES & SUBSCRIPTIONS 39847 12768 2288 24791 FILING FEES 22683 7269 1302 14112 RESEARCH MATERIALS 40 12 3 25 10316517 8895761 608130 812626 1855225 779500 15526890 12083212 5454387 2538036 54192 165948 4407652 8971945 35000 14 27333346 24538655 133430 184366 13069601 10848720 277500 497500 13480531 11530586 X 12027815 10470033 1825000 2538036 13852815 13008069 27333346 24538655 X -1024819 452009 -55525 -216411 X 0 1 X 1 0 X X X 1 THE MILKEN INSTITUTE 954240775 7 1 8945051 0 1 8945051 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 PART IV, SECTION A, LINE 6: THE AMOUNT OF SUPPORT REPORTED TO MILKEN INSTITUTE REPRESENTS ALL PROGRAMMATIC EXPENDITURES MADE TOWARDS ENDING SUFFERING AND DEATH DUE TO MELANOMA INCLUDING ISSUED GRANTS, TECHNICAL MANAGEMENT OF GRANTS PROGRAM AND PATIENT ENGAGEMENT. ALL OF THESE EXPENDITURES ADVANCE THE MISSION OF BOTH MRA AND THE MILKEN INSTITUTE. MRA PROVIDES DIRECT SUPPORT TO PUBLIC CHARITIES AND EDUCATIONAL INSTITUTIONS FOR THE PURPOSES OF CANCER RESEARCH SPECIFICALLY RELATED TO MELANOMA. SUPPORTING THESE UNRELATED RESEARCH ORGANIZATIONS DIRECTLY SUPPORTS THE MISSION OF THE MILKEN INSTITUTE SINCE PART OF THE INSTITUTE'S MISSION IS TO IMPROVE HEALTH WORLDWIDE. MRA ALSO PROVIDES PATIENT ENGAGEMENT AND EDUCATION RELATED TO MELANOMA TO IMPROVE AWARENESS OF MELANOMA AND ENGAGEMENT OF PATIENTS IN MELANOMA CLINICAL TRIALS. BY MRA PROVIDING THE GRANTS DIRECTLY TO THE CHARITIES AND EDUCATIONAL INSTITUTIONS, AND THROUGH PATIENT EDUCATION ACTIVITIES, MRA FURTHER ASSISTS THE MILKEN INSTITUTE. BECAUSE THERE IS A DIRECT LINE OF COMMUNICATION BETWEEN DONOR AND GRANT RECIPIENT, THE INSTITUTE CAN RELY ON MRA TO PROVIDE GRANT MONITORING AND GRANT SUPPORT SERVICES TO GRANT RECIPIENTS. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 9553181 9553181 627659 156915 0 0 895176 686207 900488 627659 3109530 4664295 2000 2000 2000 6000 223794 171552 225122 156915 777383 1166075 0 X 9761115 452009 210864 -170150 492723 9268392 23306 23306 9291698 10605861 210864 55525 46261 312650 10293211 23306 23306 10316517 PART X, LINE 2: MRA RECOGNIZES THE IMPACT OF TAX POSITIONS IN THE FINANCIAL STATEMENTS IF THAT POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED ON AUDIT, BASED ON THE TECHNICAL MERITS OF THE POSITION. DURING THE YEAR ENDED DECEMBER 31, 2023, MRA PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS AND DID NOT NOTE ANY MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR WHICH MIGHT HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -170,150. PART XII, LINE 2D - OTHER ADJUSTMENTS: DISCOUNT ON GRANTS 52,496. RETURN OF GRANTS TO OTHER ORGANIZATIONS -6,235. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGION 425000 0 0 0 0 0 0 425000 0 425000 EUROPE (INCLUDING ICELAND & GREENLAND) YOUNG INVESTIGATOR AWARD 425000 WIRE 0 1 1 0 0 0 0 0 PART I, LINE 2: EACH PROPOSAL TO THE MRA IS REVIEWED FOR SCIENTIFIC MERIT AND TRANSLATIONAL AND CLINICAL IMPACT BY MRA'S WORLD-CLASS GRANT REVIEW COMMITTEE (GRC). CRITERIA ARE DESCRIBED IN THE MRA'S REQUEST FOR PROPOSALS. GRC MEMBERS ARE SENIOR THOUGHT-LEADERS IN MELANOMA AND CANCER RESEARCH. AFTER SCIENTIFIC PEER REVIEW BY THE GRC, THE MRA BOARD OF DIRECTORS APPROVES FINAL RESEARCH AWARDS FOR FUNDING. RESEARCH AWARD FUNDS ARE DISPENSED ON AN ANNUAL BASIS, CONTINGENT UPON MRA STAFF REVIEW OF ANNUAL SCIENTIFIC PROGRESS AND FINANCIAL REPORTS SUBMITTED BY THE GRANTEES. PART I, LINE 3: AWARDEES PROVIDE MRA WITH ANNUAL WRITTEN REPORTS OF THEIR RESEARCH PROGRESS AND COMPLIANCE WITH BUDGET GUIDELINES. FUNDS ARE DISTRIBUTED IN ANNUAL INSTALLMENTS AND NEXT YEAR'S INSTALLMENT IS NOT PROVIDED UNTIL SATISFACTORY REVIEW BY THE MRA CHIEF SCIENCE OFFICER AND SCIENTIFIC PROGRAM DIRECTOR. AWARDEES MUST KEEP SYSTEMATIC AND COMPLETE RECORDS ON THE RECEIPT AND DISBURSEMENT OF ALL AWARD FUNDS, AND MAY NOT COMMINGLE ANY FUNDS FROM OTHER SOURCES. PART IV, LINE 1 FORM 926 IS NOT REQUIRED TO BE FILED BECAUSE THE TRANSFER TO A FOREIGN CORPORATION DOES NOT MEET THE REQPORTING REQUIREMENTS IN IRC SEC. 6038(A)(1)(A). LEVERAGED FINANCE FIGHT 3090220 2967620 122600 85000 93359 100076 MRA LIVE SALON ASPEN 25300 25300 2994 2 30100 30100 1560 893 3145620 3023020 122600 85000 94919 103963 283882 -161282 1 UNIVERSITY OF VIRGINIA 1001 N EMMET STREET CHARLOTTESVILLE VA 22903 546001796 PUBLIC UNIVERSITY 375000 0 ESTABLISHED INVESTIGATOR AWARD THE UNIVERSITY OF IOWA 105 JESSUP HALL IOWA CITY IA 52242 426004813 PUBLIC UNIVERSITY 375000 0 ESTABLISHED INVESTIGATOR AWARD REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BLVD SUITE 700 LOS ANGELES CA 900951406 956006143 PUBLIC UNIVERSITY 50000 0 DERMATOLOGY FELLOWS AWARD FRED HUTCHINSON CANCER CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 911935159 501(C)(3) 255000 0 YOUNG INVESTIGATOR AWARD THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 131624158 501(C)(3) 50000 0 DERMATOLOGY FELLOWS AWARD MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 501(C)(3) 255000 0 YOUNG INVESTIGATOR AWARD HLEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 241320 0 YOUNG INVESTIGATOR AWARD WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVE NEW YORK NY 10065 131623978 PUBLIC UNIVERSITY 375000 0 ESTABLISHED INVESTIGATOR AWARD LEWIS KATZ SCHOOLOF MEDICINE TEMPLE UNIVERSITY 1852 N 10TH STREET PHILADELPHIA PA 19122 231365971 501(C)(3) 50000 0 PILOT AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET SUITE 425 SAN FRANCISCO CA 94143 946036493 PUBLIC UNIVERSITY 255000 0 YOUNG INVESTIGATOR AWARD UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE RM 411 SALT LAKE CITY UT 84112 876000525 PUBLIC UNIVERSITY 100000 0 PILOT AWARD DUKE UNIVERSITY 230 RESEARCH DRIVE MSR81 DURHAM NC 27710 560532129 501(C)(3) 110000 0 MRA IN TRANSIT MELANOMA CONSORTIUM AWARD YALE UNIVERSITY 230 SOUTH FRONTAGE NEW HAVEN CT 06520 060646973 PUBLIC UNIVERSITY 50000 0 DERMATOLOGY FELLOWS AWARD INSTITUTE OF CANCER RESEARCH DBA THE RESEARCH INS OF FOX CHASE CANCER CTR 333 COTTMAN AVENUE PHILADELPHIA PA 19111 236296135 501(C)(3) 100000 0 PILOT AWARD CHILDREN'S HOSPITAL OF PHILADELPHIA 3401 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501(C)(3) 255000 0 YOUNG INVESTIGATOR AWARD JOHNS HOPKINS UNIVERSITY 3910 KESWICK ROAD N4327-B BALTIMORE MD 21211 520595110 501(C)(3) 442500 0 YOUNG INVESTIGATOR AWARD CORIELL INSTITUTE FOR MEDICAL RESEARCH INC 403 HADDON AVENUE CAMDEN NJ 081031505 210672684 501(C)(3) 50000 0 PILOT AWARD THE REGENTS OF THE UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 SOUTH STATE STREET ANN ARBOR MI 481091287 386006309 PUBLIC UNIVERSITY 187500 0 ESTABLISHED INVESTIGATOR AWARD THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)(3) 255000 0 YOUNG INVESTIGATOR AWARD NEW YORK UNIVERSITY GROSSMAN SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 PUBLIC UNIVERSITY 800000 0 1 DERMATOLOGY FELLOWS AWARD, 2 ESTABLISHED INVESTIGATOR AWARDS NORTHWESTERN UNIVERSITY 633 CLARK STREET EVANSTON IL 60208 362167817 PUBLIC UNIVERSITY 375000 0 ESTABLISHED INVESTIGATOR AWARD TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501(C)(3) 100000 0 PILOT AWARD THE CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501(C)(3) 254862 0 YOUNG INVESTIGATOR AWARD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE NEW YORK NY 100296574 136171197 501(C)(3) 354160 0 1 PILOT AWARD, 1 YOUNG INVESTIGATOR AWARD THE BRIGHAM AND WOMEN'S HOSPITAL INC RESEARCH FINANCE C/O BANK OF AMERICA POBOX 3149 BOSTON MA 02241 042312909 501(C)(3) 85000 0 YOUNG INVESTIGATOR AWARD UNIVERSITY OF SOUTHERN CALIFORNIA UNIVERSITY GARDENS BUILDING STE 205 LOS ANGELES CA 900898006 951642394 501(C)(3) 375000 0 ESTABLISHED INVESTIGATOR AWARD 26 0 PART I, LINE 2: GRANTS ISSUED WITHIN THE UNITED STATES ARE SELECTED BASED ON SUBMISSIONS PROVIDED IN RESPONSE TO MRA REQUEST FOR PROPOSALS. APPLICANTS ARE REVIEWED FOR ELIGIBILITY - AND ELIGIBLE APPLICANTS ARE THEN REVIEWED BY PEER-SCIENTISTS, SCORED THROUGH THE PEER REVIEW PROCESS AND RANKED. APPLICATIONS MERITING AWARDS THROUGH PEER-REVIEW ARE THEN REVIEWED AGAINST EXISTING MRA PORTFOLIO AND FINAL SLATE OF PROPOSED GRANTS ARE MOVED TO THE FULL BOARD OF DIRECTORS FOR THEIR REVIEW PRIOR TO ISSUANCE. ALL GRANTEES, DOMESTIC AND INTERNATIONAL, ARE REQUIRED TO SUBMIT ANNUAL TECHNICAL PROGRESS REPORTS AND FINANCIAL REPORTS PRIOR TO RECEIVING THE NEXT YEAR OF FUNDING UNDER GRANT AGREEMENT. GRANTEES ARE ALSO INVITED TO PRESENT THEIR DATA AT MRA ANNUAL SCIENTIFIC RETREAT TO GATHER FEEDBACK/INPUT FROM PEERS AND PERIODIC SITE VISITS BY MRA STAFF WITH GRANTEES ARE CONDUCTED SOMETIMES VIA VIRTUAL AND OTHER TIMES IN PERSON VISITS. X X X 0 0 0 0 0 0 0 1 0 MICHAEL KLOWDEN DIRECTOR 0 415282 0 0 0 6108 0 16500 0 40259 0 478149 0 0 JOHN HUNTER TREASURER 0 411497 0 75000 0 3810 0 16500 0 56624 0 563431 0 0 MARC HURLBERT CHIEF EXECUTIVE OFFICER 358659 0 20000 0 0 0 16500 0 18940 0 414099 0 0 0 STEPHANIE KAUFFMAN PRESIDENT & COO 290852 0 10000 0 0 0 15080 0 51248 0 367180 0 0 0 JOAN LEVY CHIEF SCIENCE OFFICER 193854 0 5000 0 0 0 9785 0 18526 0 227165 0 0 0 TANISHA JACKSON SCIENTIFIC PROGRAM DIRECTOR 155659 0 0 0 0 0 7875 0 18371 0 181905 0 0 0 PART I, LINE 7 EMPLOYEES WERE ELIGIBLE TO RECEIVE PERFORMANCE-BASED BONUSES. X 2 153244 FAIR MARKET VALUE 0 1 0 PART I, COLUMN (B): NONCASH DONATIONS ARE LISTED BY TOTAL NUMBER OF DONORS. FORM 990, PART VI, SECTION A, LINE 2 DEBRA BLACK, LEON BLACK AND BEN BLACK HAVE A FAMILY RELATIONSHIP. DEBRA BLACK AND RICHARD RESSLER HAVE A FAMILY RELATIONSHIP. JAMI GERTZ AND DEBRA BLACK HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 8B THERE IS NO EXECUTIVE COMMITTEE DURING THE YEAR. FORM 990, PART VI, SECTION B, LINE 11B MRA'S CEO, PRESIDENT& COO AND TREASURER REVIEW THE FORM 990. THE FINAL DRAFT IS DISTRIBUTED ELECTRONICALLY TO ALL THE BOARD MEMBERS BEFORE THE CEO SIGNS THE DOCUMENT AND IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AS STATED IN THE MRA BYLAWS, EACH DIRECTOR, TRUSTEE, PRINCIPAL OFFICER, AND MEMBER OF A COMMITTEE OF THE BOARD IS TO SIGN A STATEMENT ANNUALLY AFFIRMING THEY HAVE RECEIVED THE CONFLICT OF INTEREST POLICY, THEY HAVE READ AND UNDERSTAND IT, AND THEY AGREE TO COMPLY WITH IT. UPON POTENTIAL CONFLICT OF INTERESTS, THE BOARD OR COMMITTEE WILL RESOLVE THE CONFLICT IN THE BEST INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 ACCORDING TO THE MRA BYLAWS, MEMBERS OF THE BOARD REVIEW AND APPROVE THE MRA CEO AND KEY EMPLOYEES SALARY TO ENSURE IT IS JUST AND REASONABLE. DURING THIS ANNUAL REVIEW, MEMBERS OF THE BOARD USE THE FEDERAL FORM 990 OF OTHER ORGANIZATIONS FOR COMPARABLES. LINE 15B EXPLANATION: MEMBERS OF THE BOARD AND MRA LEADERSHIP CONDUCT AN ANNUAL REVIEW OF ITS COMPENSATION PHILOSOPHY AND UTILIZE COMPETITIVE BENCHMARKING DATA TO ENSURE COMPENSATION IS JUST AND REASONABLE. FORM 990, PART VI, SECTION C, LINE 19 MRA MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. A COPY OF FORM 990 AND THE AUDITED FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE. FORM 990, PART XI, LINE 9: LOSS ON WRITE-OFF OF UNCOLLECTIBLE PLEDGES RECEIVABLE -170,150. DISCOUNT ON GRANTS -52,496. RETURN OF GRANTS TO OTHER ORGANIZATIONS 6,235. MILKEN INSTITUTE 1250 FOURTH STREET SANTA MONICA CA 90401 954240775 EDUCATIONAL, ECONOMIC RESEARCH, HEALTHCARE RESEARCH CA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0